Conditions: Healthy Volunteers
Keywords: Bioequivalence Healthy Volunteers
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 36
Healthy volunteers: yes

Brief summary:
This is a bioequivalence trial to evaluate the bioequivalence of Myrin P Forte against reference drug in healthy volunteers.

Detailed description:

Arms:
arm 1: Test Myrin P Forte Contains 150mg Rifampicin, 75mg Isoniazid, 275mg Ethambutol, 400mg Pyrazinamide arm 2: Reference Single drug reference preparations contain Rifampicin, Isoniazid, Ethambutol, Pyrazinamide

Interventions: intervention 1: Myrin P Forte intervention 2: Single drug references
Intervention descriptions: intervention 1: Tablet containing Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, given once daily, single dose intervention 2: containing Rifampicin, Isoniazid, Ethambutol and Pyrazinamide as single agents

Protocol document: